MiR-299-3p Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Migration by Targeting MMP-2.

PURPOSE

Nasopharyngeal carcinoma (NPC) is a type of squamous cell carcinoma that originated from the epithelial cells of the nose and throat, and its incidence ranks the first among head and neck tumors. However, NPC has a unique and complex etiology that is not completely understood. MiR-299-3p was discovered to be abnormally expressed in cancers. However, the involvement of miR-299-3p in the incidence and progression of nasopharyngeal cancer remains unknown.

METHODS

The miR-299-3p expression in nasopharyngeal cancer samples and cell lines was identified using quantitative PCR (qPCR). Nasopharyngeal cancer cells were evaluated for proliferation, migration, and invasion using MTT, colony formation assay, and Transwell invasion assay. MiRBase and TargetScan databases identified the possible miR-299-3p target genes that were confirmed using a dual-luciferase reporter analysis. Additionally, the miR-299-3p target genes were validated by Western blot, colony formation assay, and Transwell assays.

RESULTS

It was found that miR-299-3p expression was low in nasopharyngeal cancer tissues and cell lines, according to qPCR data. Cell proliferation, colony formation, and migration were considerably reduced by miR-299-3p overexpression. Furthermore, matrix metalloproteinase 2 (MMP-2) expression was regulated by miR-299-3p, whereas MMP-2 knockdown significantly inhibited the capacity of nasopharyngeal cancer cells to form colonies and migrate. Overexpression of MMP-2 substantially reduced the miR-299-3p inhibitory impact on nasopharyngeal cancer cell migration and colony formation.

CONCLUSION

The miR-299-3p acts as a tumor suppressor gene to suppress the growth and spread of nasopharyngeal cancer by regulating MMP-2 expression. Therefore, miR-299-3p and MMP-2 could be important therapeutic targets for suppressing nasopharyngeal cancer growth and metastasis.